OCGN FY 2017 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$710M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$25M

Net Income

-$26M

EPS (Diluted)

$-69.91

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$11M

Total Liabilities

$22M

Stockholders' Equity

-$11M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$2M	+8.3%
Operating Income	-$25M	-$30M	+17.7%
Net Income	-$26M	-$16M	-63.0%